← FDA DRUG APPROVALS

FDA NDA · NDA012754

TORECAN

Sponsor: NOVARTIS

APPLICATION
NDA012754
TYPE
NDA
ORIGINAL APPROVAL
1961-07-18
LATEST ACTION
2001-05-10
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TORECANDiscontinued
THIETHYLPERAZINE MALATE 5MG/ML · INJECTABLE · INJECTION

Approval history

2001-05-10Manufacturing (CMC) · Supplement 35 · standardAP
1997-08-06Labeling · Supplement 28AP
1997-08-06Labeling · Supplement 34 · standardAP
1997-08-06Labeling · Supplement 25AP
1996-12-17Manufacturing (CMC) · Supplement 33 · standardAP
1995-09-19Manufacturing (CMC) · Supplement 32 · standardAP
1993-09-14Manufacturing (CMC) · Supplement 27 · standardAP
1993-09-02Manufacturing (CMC) · Supplement 29 · standardAP
1993-07-08Manufacturing (CMC) · Supplement 31 · standardAP
1989-09-22Manufacturing (CMC) · Supplement 24 · standardAP
1989-08-08Labeling · Supplement 23AP
1989-02-28Manufacturing (CMC) · Supplement 21 · standardAP
1988-04-20Manufacturing (CMC) · Supplement 16 · standardAP
1961-07-18Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →